Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study.

Swedberg K, Komajda M, Böhm M, Borer JS, Ford I, Dubost-Brama A, Lerebours G, Tavazzi L; SHIFT Investigators.

Lancet. 2010 Sep 11;376(9744):875-85. doi: 10.1016/S0140-6736(10)61198-1. Erratum in: Lancet. 2010 Dec 11;376(9757):1988. Lajnscak, M [corrected to Lainscak, M]; Rabanedo, I Roldan [corrected to Rabadán, I Roldan]; Leva, M [corrected to Ieva, M].

PMID:
20801500
2.
3.

Characterization of peripheral arterial wall motion by Doppler tissue echography: a validation study.

Pelle G, Pascal O, Adnot S, Gueret P, Dubois-Randé JL, Belhassen L.

J Am Soc Echocardiogr. 2002 Oct;15(10 Pt 2):1218-25.

PMID:
12411908
4.

Evaluation of carotid artery and aortic intima-media thickness measurements for exclusion of significant coronary atherosclerosis in patients scheduled for heart valve surgery.

Belhassen L, Carville C, Pelle G, Monin JL, Teiger E, Duval-Moulin AM, Dupouy P, Dubois Rande JL, Gueret P.

J Am Coll Cardiol. 2002 Apr 3;39(7):1139-44.

5.

Endothelial dysfunction in patients with sickle cell disease is related to selective impairment of shear stress-mediated vasodilation.

Belhassen L, Pelle G, Sediame S, Bachir D, Carville C, Bucherer C, Lacombe C, Galacteros F, Adnot S.

Blood. 2001 Mar 15;97(6):1584-9.

6.

[Vasodilator effects of bradykinin on the resistive circulation of the forearm of coronary patients].

Benacerraf S, Carville C, Sediame S, Belhassen L, Adnot S, Dubois-Randé JL.

Arch Mal Coeur Vaiss. 2000 Sep;93(9):1103-8. French.

PMID:
11055001
7.

Molsidomine improves flow-dependent vasodilation in brachial arteries of patients with coronary artery disease.

Belhassen L, Carville C, Pelle G, Sediame S, Benacerraf S, Dubois-Randé JL, Adnot S.

J Cardiovasc Pharmacol. 2000 Apr;35(4):560-3.

PMID:
10774786
8.

Improvement of bradykinin endothelium-mediated vasodilation of forearm resistance circulation by quinaprilat in patients with coronary artery disease with or without left ventricular dysfunction.

Benacerraf S, Carville C, Adnot S, Montagne O, Sediame S, Belhassen L, Dubois-Randé JL.

J Cardiovasc Pharmacol. 1999 Sep;34(3):368-73.

PMID:
10470994
9.
10.

Endothelial nitric oxide synthase targeting to caveolae. Specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells.

Feron O, Belhassen L, Kobzik L, Smith TW, Kelly RA, Michel T.

J Biol Chem. 1996 Sep 13;271(37):22810-4.

12.

Nitric oxide-dependent parasympathetic signaling is due to activation of constitutive endothelial (type III) nitric oxide synthase in cardiac myocytes.

Balligand JL, Kobzik L, Han X, Kaye DM, Belhassen L, O'Hara DS, Kelly RA, Smith TW, Michel T.

J Biol Chem. 1995 Jun 16;270(24):14582-6.

13.
14.

[Chronic obstructions of the left main and right coronary arteries].

Fourchard V, Belhassen L, Chagnon P, Lapierre S, Debauchez C, Cattan S, Gryman R.

Arch Mal Coeur Vaiss. 1993 Nov;86(11):1633-5. French.

PMID:
8010864

Supplemental Content

Loading ...
Support Center